Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Epizyme Inc (EPZM)

Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Epizyme Inc 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 USA

www.epizyme.com P: 617-229-5872 F: 617-349-0707

Description:

Epizyme is a development-stage biopharmaceutical company, focused on bringing novel epigenetic therapies for the treatment of cancer and other diseases to the market. The company's proprietary product platform is used to create small molecule inhibitors of a class of enzymes known as histone methyltransferases (HMTs). Epizyme's focus is on inhibiting oncogenic HMTs for the treatment of the underlying causes of associated cancers.

Key Statistics

Overview:

Market Capitalization, $K 247,444
Enterprise Value, $K 247,619
Shares Outstanding, K 168,329
Annual Sales, $ 37,430 K
Annual Net Income, $ -251,120 K
Last Quarter Sales, $ 8,700 K
Last Quarter Net Income, $ -55,510 K
60-Month Beta -0.41
% of Insider Shareholders 23.40%
% of Institutional Shareholders 76.45%
Float, K 128,940
% Float 76.60%
Short Volume Ratio 0.23

Growth:

1-Year Return -73.18%
3-Year Return -89.29%
5-Year Return -89.54%
5-Year Revenue Growth 367.29%
5-Year Earnings Growth -26.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 08/09/22
Next Earnings Date 08/08/22
Earnings Per Share ttm -2.15
EPS Growth vs. Prev Qtr 46.15%
EPS Growth vs. Prev Year 66.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

EPZM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -69.74%
Profit Margin % -670.91%
Debt/Equity -10.69
Price/Sales 6.70
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.07
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar